Sun Pharmaceutical Industries Second Quarter Profit Is Expected To Fall

Sun Pharmaceutical Industries' second quarter profit is expected to fall sharply by 64 percent year-on-year to Rs 802 crore due to lower revenue as well as operating income.

Revenue during the quarter is seen declining 17 percent to Rs 6,861 crore compared with Rs 8,265 crore in same quarter last fiscal, according to average of estimates of analysts polled by CNBC-TV18.

EBITDA (earnings before interest, tax, depreciation and amortisation) is likely to fall 57 percent to Rs 1,357.4 crore and margin may shrink 1830 basis points to 20 percent YoY.

For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory